Mirum Pharmaceuticals Inc. | Mid-cap | Healthcare

Mirum Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: $50.69 High: $53.86
on July 9, 2025

52 Week Range

Low: $35.11 High: $54.23
on July 9, 2024
on February 21, 2025

All-Time High: $54.23 on February 17, 2025

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $2.5B
EPS i N/A
P/E Ratio (TTM) i -28.62
Forward P/E i -57.23
P/B Ratio i 10.56
PEG Ratio i -57.23
Div. Yield i N/A
ROE i -33.06%
Beta i N/A
Debt to Equity i 135.97

Financial Highlights

Profitability

Gross Margin i 79.37%
Operating Margin i N/A
Profit Margin i N/A

Returns and Earnings

Return on Assets (TTM) i N/A
Return on Equity (TTM) i -33.06%
EBITDA i N/A
Net Income (TTM) i N/A

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i
Quarterly Revenue Growth i
Quarterly Earnings Growth i

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Mirum MIRM 2.47B Mid-cap8.90%13.62%28.91%29.38%27.16%27.46%108.33%149.23%
Vertex VRTX 114.06B Large-cap4.80%7.35%-0.69%16.95%18.04%-4.58%59.25%58.34%
Regeneron REGN 59.14B Large-cap0.88%6.76%-4.19%-20.71%-22.74%-50.21%-9.84%-14.95%
Blueprint Medicines BPMC 8.30B Mid-cap0.27%0.45%56.67%47.03%47.42%9.02%139.78%65.31%
Roivant Sciences ROIV 7.38B Mid-cap2.28%1.26%13.45%5.55%-7.12%-4.32%154.33%9.48%
Bio-Techne TECH 7.92B Mid-cap-1.11%5.43%-2.74%-28.26%-26.43%-31.86%-38.81%-24.68%

Ownership & Short Interest

Insider Ownership i 1.91%
Institutional Ownership i 114.12%
Shares Short i 6M
Short Ratio i 16.87
Short % of Shares Outstanding i 12.55%
Average 10-Day Volume i 416K
Average 90-Day Volume i 426K

Mirum Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Mirum would have performed over time.

$
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is MIRM's 52-week high and low?

In the last 52 weeks, Mirum reached a high of $54.23 (on February 21, 2025) and a low of $35.11 (on July 9, 2024).

What is the market cap and P/E ratio for MIRM?

Curious about Mirum's size and valuation? Its market capitalization stands at 2.47B. When it comes to valuation, the P/E ratio (trailing twelve months) is -28.62, and the forward P/E (looking ahead) is -57.23.

Does MIRM pay dividends? If so, what's the yield?

As for dividends, Mirum isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Mirum's main competitors or similar companies to consider before investing?

When looking at Mirum, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Vertex
VRTX
114.06BHealthcareBiotechnology-4.58%59.25%
Regeneron
REGN
59.14BHealthcareBiotechnology-50.21%-9.84%
Blueprint Medicines
BPMC
8.30BHealthcareBiotechnology9.02%139.78%
Roivant Sciences
ROIV
7.38BHealthcareBiotechnology-4.32%154.33%
Bio-Techne
TECH
7.92BHealthcareBiotechnology-31.86%-38.81%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Mirum Pharmaceuticals Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Mirum's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -33.06%, the Debt to Equity ratio from the most recent quarter is 135.97, and its Gross Profit Margin stands at 79.37%.

What is the recent revenue and earnings growth for MIRM?

Looking at Mirum's growth, its revenue over the trailing twelve months (TTM) was $379M. Compared to the same quarter last year (YoY), quarterly revenue grew by 61.20%, and quarterly earnings saw a YoY growth of 61.20%.

How much of MIRM stock is held by insiders and institutions?

Wondering who owns Mirum stock? Company insiders (like executives and directors) hold about 1.91% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 114.12%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.